Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Exora Medical is an Israeli medical device company focused on developing innovative, minimally invasive solutions for the treatment of obesity and related metabolic disorders. The company's lead technology is a non-surgical, endoscopically delivered gastric implant designed to induce weight loss by mimicking the effects of bariatric surgery without the associated risks and recovery time. By targeting the physiological mechanisms of satiety and gastric emptying, Exora aims to provide a reversible and effective alternative for patients who do not qualify for or wish to avoid traditional surgery. The company is currently advancing its clinical programs to validate the safety and efficacy of its device in human trials.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Exora.